Gerald J. Mizejewski, PhD, always had a desire to teach and conduct cancer research to benefit mankind. After achieving his doctoral degree at the University of Maryland in 1967, he commenced his postdoctoral career as a research assistant in Maryland’s Department of Veterinary Medicine campus-based Agricultural Station from 1967 to 1968. While at the station, he developed a diagnostic test for the Avian Bronchitis Virus in poultry. The following year, he was awarded and accepted a research associate fellowship at the University of Michigan’s Department of Internal Medicine within the Nuclear Medicine Division and taught as an instructor in their School of Public Health. While at Michigan, he co-served as a research physiologist at the campus VA Hospital. Relocating to the East Coast after three years, he was appointed an assistant professor in the Department of Biology at the University of South Carolina from 1971 to 1974. He subsequently relocated after accepting a position as a research scientist at the New York State Department of Health, Division of Labs and Research, and served from 1974 to 1979.
After that time, Dr. Mizejewski was promoted to senior research scientist in the New York State Wadsworth Research Center, a position he still holds today. During his Wadsworth tenure, he dedicated his time to direct the Oncofetal Antigen Laboratory for five years. Afterward, he became assistant director of the New York State Hypothyroid Newborn Screening Laboratory for eight years and taught as an associate professor at the New York State University School of Public Health. Since 1999, he has overseen and directed the Wadsworth’s Fetal Defect Markers Proficiency Testing Program in the
New York State Health Department.
In the course of his career, Dr. Mizejewski has compiled training and experience in animal surgery, light and electron microscopy, protein/peptide isolation and purification, cell-based testing and immunoassays. As a professor, he has taught university courses in cell biology, human anatomy and physiology, immunology and serology, histology, and cancer and fetal biomarkers. Over the years, Dr. Mizejewski has developed several U.S. patents for the development of Alpha-fetoprotein growth inhibitory and cancer peptides for diagnostic and therapeutic use in cancer monitoring, growth and metastasis. A prolific author, he has published 150 peer-reviewed journal articles, gave 120 conference presentations, contributed 16 book chapters, co-edited four books on Alpha-fetoprotein and authored one secular book. Civically involved as well, he has participated in executive roles in election booth activities, the American Cancer Society, the Cystic Fibrosis Foundation, the Alzheimer’s Association, the National Kidney Foundation, the Boy Scouts of America, the Christian Service Brigades and the YMCA Indian Guides Program, among other notable organizations.
In light of his outstanding contributions to oncology, biomedical research and education, Dr. Mizejewski received grants from the National Cancer Institute and private organizations, and was awarded a National Science Foundation fellowship to research marine embryology for six weeks at the Biological Station in Bermuda. A member of the U.S. Marine Corps, he attributes his success to his gift of creativity in science, biology and
biochemistry research. Looking toward the future, Dr. Mizejewski intends to continue researching anti-cancer therapeutic agents and working for the Wadsworth Research Center.
Contact Dr. Mizejewski:
